XML 60 R40.htm IDEA: XBRL DOCUMENT v3.25.4
Acquisitions, Dispositions and Plant Closures (Tables)
 12 Months Ended
Dec. 31, 2025
Acquisitions, Dispositions and Plant Closures [Abstract]  
Schedule of Assets and Liabilities Classified as Held for Sale
Assets and liabilities classified as held for sale are as follows:
As of December 31, 2025
(In $ millions)
Current assets91 
Goodwill154 
Intangible assets, net163 
Other long-term assets84 
Assets held for sale492 
Liabilities held for sale75 
Schedule of Restructuring and Related Costs
Exit and shutdown costs related to plant closures are as follows:
Year Ended December 31,
202520242023
(In $ millions)
Lanaken, Belgium(1)
Restructuring (Note 24)
7 — — 
Accelerated depreciation expense(2)
11 — — 
Total18 — — 
Mechelen, Belgium(3)
Restructuring (Note 24)
3 55 — 
Accelerated depreciation expense(2)
— 35 — 
Total3 90 — 
Uentrop, Germany(4)
Restructuring (Note 24)
— 16 — 
Accelerated depreciation expense(2)
— 36 14 
Loss on disposition of assets, net(5)
— — 4 
Total— 52 18 
______________________________
(1)On October 28, 2025, the Company announced the intended closure of its facility in Lanaken, Belgium to streamline the Company's production costs across its global network. This operation is included in the Company's Acetyl Chain segment. The Company intends to permanently cease all manufacturing operations during the second half of 2026.
The Company expects to incur additional exit and shutdown costs related to the intended closure of its facility in Lanaken, Belgium of $140 million, including employee termination costs, through 2027.
(2)Included in Cost of sales in the consolidated statements of operations.
(3)In February 2024, the Company announced the intended closure of its facility in Mechelen, Belgium to optimize production costs across its global network. This operation is included in the Company's Engineered Materials segment. The Company fully ceased operations during the year ended December 31, 2024.
(4)In October 2023, the Company announced the intended closure of its Polyamide 66 ("PA66") and certain High-Performance Nylon ("HPN") polymerization units at its facility in Uentrop, Germany to optimize production costs across its global network. These operations are included in the Company's Engineered Materials segment. The Company fully ceased operation of the PA66 polymerization unit and certain HPN polymerization units during the year ended December 31, 2024.
(5)Included in Gain (loss) on disposition of businesses and assets, net in the consolidated statements of operations.